Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8081851rdf:typepubmed:Citationlld:pubmed
pubmed-article:8081851lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:8081851lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8081851lifeskim:mentionsumls-concept:C0205549lld:lifeskim
pubmed-article:8081851lifeskim:mentionsumls-concept:C1514555lld:lifeskim
pubmed-article:8081851pubmed:issue3lld:pubmed
pubmed-article:8081851pubmed:dateCreated1994-10-10lld:pubmed
pubmed-article:8081851pubmed:abstractTextTo assess the role of the cyclic amide moiety in indolocarbazole and bis-indole protein kinase C inhibitors, five amides in these series were synthesized in which the amide group is acyclic. These new compounds have no inhibitory effect on protein kinase C, indicating that the rigid cyclic structure of the amide group is compulsory for biological activity.lld:pubmed
pubmed-article:8081851pubmed:languageenglld:pubmed
pubmed-article:8081851pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081851pubmed:citationSubsetIMlld:pubmed
pubmed-article:8081851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081851pubmed:statusMEDLINElld:pubmed
pubmed-article:8081851pubmed:monthSeplld:pubmed
pubmed-article:8081851pubmed:issn0968-0896lld:pubmed
pubmed-article:8081851pubmed:authorpubmed-author:FabreSSlld:pubmed
pubmed-article:8081851pubmed:authorpubmed-author:PrudhommeMMlld:pubmed
pubmed-article:8081851pubmed:authorpubmed-author:RappMMlld:pubmed
pubmed-article:8081851pubmed:issnTypePrintlld:pubmed
pubmed-article:8081851pubmed:volume1lld:pubmed
pubmed-article:8081851pubmed:ownerNLMlld:pubmed
pubmed-article:8081851pubmed:authorsCompleteYlld:pubmed
pubmed-article:8081851pubmed:pagination189-92lld:pubmed
pubmed-article:8081851pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:meshHeadingpubmed-meshheading:8081851-...lld:pubmed
pubmed-article:8081851pubmed:year1993lld:pubmed
pubmed-article:8081851pubmed:articleTitleStudies on protein kinase C inhibitors; structure-activity relationships in indolocarbazole and bis-indole series.lld:pubmed
pubmed-article:8081851pubmed:affiliationUniversité Blaise Pascal, Laboratoire de Chimie Organique Biologique, URA 485, Aubière, France.lld:pubmed
pubmed-article:8081851pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8081851pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8081851pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed